Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Deferasirox (Exjade®) Given During Conditioning Regimen (FLAMSA/Busulfan/ATG) Reduces the Appearance of Labile Plasma Iron in Patients Undergoing Allogeneic Stem Cell Transplantation

Annekathrin Fritsch, Claudia Langebrake, PhD, Peter Nielsen, MD, Ulrike Bacher, MD, Michael Baehr, PhD, Dorothee C. Dartsch, PhD, Nicolaus Kroeger, M.D.

Blood (2011) 118 (21): 3023.

https://doi.org/10.1182/blood.V118.21.3023.3023

Published: 2011

Journal Articles

Overexpression of the Differentiation-Defective G-CSF Receptor Isoform IV Is Associated with a High Incidence of Relapses in Childhood Acute Myeloid Leukemia Treated with G-CSF

Stephanie Ehlers, MD, Christin Herbst, Martin Zimmermann, PhD, Nicole Scharn, Manuela Germeshausen, PhD, Claudia Langebrake, PhD, Thomas Lehrnbecher, MD, Jochen Harbott, PhD, Jan Stary, MD, PhD, Michael Dworzak, MD, Ursula Creutzig, MD, Dirk Reinhardt, MD, PhD

Blood (2008) 112 (11): 2528.

https://doi.org/10.1182/blood.V112.11.2528.2528

Published: 2008

Journal Articles

Preanalytical mRNA Stabilization of Whole Bone Marrow Samples.

Claudia Langebrake, PhD, Kalle Guenther, PhD, Juergen Lauber, PhD, Dirk Reinhardt, MD

Blood (2006) 108 (11): 4407.

https://doi.org/10.1182/blood.V108.11.4407.4407

Published: 2006

Journal Articles

Minimal Residual Disease Monitoring by Four Color Flow Cytometry before Second Induction Is an Independent Prognostic Factor in Childhood Acute Myeloid Leukemia - AML-BFM MRD Study Group.

Claudia Langebrake, PhD, Michael Dworzak, MD, Ondrej Hrusak, MD, Ester Mejstrikova, MD, Frank Griesinger, MD, Martin Zimmermann, PhD, Ursula Creutzig, MD, Dirk Reinhardt, MD

Blood (2005) 106 (11): 671.

https://doi.org/10.1182/blood.V106.11.671.671

Published: 2005

Journal Articles

Chromosome 21 Encoded RUNX1 and ETS-2 Overexpression in Regenerating Hematopoiesis in Children with Down Syndrome - Implications for Leukemiogenesis?.

Dirk Reinhardt, MD, PhD, Kristin Wortmann, Miriam Kolar, Jan H. Klusmann, Ulrike Puhlmann, Jean P. Bourquin, MD, Ursula Creutzig, MD, PhD, Claudia Langebrake, PhD

Blood (2005) 106 (11): 4373.

https://doi.org/10.1182/blood.V106.11.4373.4373

Published: 2005

Journal Articles

Acute Megakaryoblastic Leukemia in Children without Down’s Syndrome.

Dirk Reinhardt, MD, Sylke Diekamp, MD, Joerg Ritter, MD, PhD, Claudia Langebrake, PhD, Gudrun Fleischhack, MD, PhD, Michael Dworzak, MD, PhD, Jan Stary, MD, Jochen Harbott, PhD, Wolf-Dieter Ludwig, MD, PhD, Ursula Creutzig, MD, PhD

Blood (2004) 104 (11): 401.

https://doi.org/10.1182/blood.V104.11.401.401

Published: 2004

NARROW

Deferasirox (Exjade®) Given During Conditioning Regimen (FLAMSA/Busulfan/ATG) Reduces the Appearance of Labile Plasma Iron in Patients Undergoing Allogeneic Stem Cell Transplantation

Overexpression of the Differentiation-Defective G-CSF Receptor Isoform IV Is Associated with a High Incidence of Relapses in Childhood Acute Myeloid Leukemia Treated with G-CSF

Preanalytical mRNA Stabilization of Whole Bone Marrow Samples.

Minimal Residual Disease Monitoring by Four Color Flow Cytometry before Second Induction Is an Independent Prognostic Factor in Childhood Acute Myeloid Leukemia - AML-BFM MRD Study Group.

Chromosome 21 Encoded RUNX1 and ETS-2 Overexpression in Regenerating Hematopoiesis in Children with Down Syndrome - Implications for Leukemiogenesis?.

Acute Megakaryoblastic Leukemia in Children without Down’s Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Deferasirox (Exjade®) Given During Conditioning Regimen (FLAMSA/Busulfan/ATG) Reduces the Appearance of Labile Plasma Iron in Patients Undergoing Allogeneic Stem Cell Transplantation

Overexpression of the Differentiation-Defective G-CSF Receptor Isoform IV Is Associated with a High Incidence of Relapses in Childhood Acute Myeloid Leukemia Treated with G-CSF

Preanalytical mRNA Stabilization of Whole Bone Marrow Samples.

Minimal Residual Disease Monitoring by Four Color Flow Cytometry before Second Induction Is an Independent Prognostic Factor in Childhood Acute Myeloid Leukemia - AML-BFM MRD Study Group.

Chromosome 21 Encoded RUNX1 and ETS-2 Overexpression in Regenerating Hematopoiesis in Children with Down Syndrome - Implications for Leukemiogenesis?.

Acute Megakaryoblastic Leukemia in Children without Down’s Syndrome.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only